• Torin2: Precision mTOR Inhibitor Workflows for Cancer Resear

  2026-05-05

  Torin2 stands out as a next-generation mTOR inhibitor, offering unmatched potency and selectivity for dissecting PI3K/Akt/mTOR signaling in cancer research. This article delivers actionable protocols, advanced troubleshooting, and workflow innovations that leverage Torin2's unique properties—accelerating insights into regulated cell death and therapeutic resistance.

• Torin2 in Cancer Research: Quantitative Assay Design and mTO

  2026-05-04

  Explore how Torin2, a potent mTOR inhibitor, transforms quantitative assay design and cancer research. This article uncovers practical strategies, mechanistic depth, and new perspectives beyond standard workflows.

• Amyloid Beta-Peptide (1-40) (human): Beyond Plaques—Emerging

  2026-05-04

  Explore the novel biological functions of Amyloid Beta-Peptide (1-40) (human) in brain development and microglial regulation. This article offers advanced insights for Alzheimer’s disease research peptide applications, grounded in cutting-edge scientific evidence.

• Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2

  2026-05-03

  This study offers a detailed characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the COVID-19 pandemic, revealing high multidrug resistance and dominant plasmid-mediated blaNDM-1 dissemination. The work advances understanding of horizontal gene transfer and resistance epidemiology, informing both surveillance and experimental modeling.

• Benzyl-Activated Streptavidin Magnetic Beads (SKU: K1301) in

  2026-05-02

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the need for selective, reproducible capture of biotinylated molecules in protein, antibody, and nucleic acid workflows. This product is best suited for high-specificity applications such as immunoprecipitation assays, protein interaction studies, and advanced screening where low nonspecific binding is critical. Not recommended for non-biotinylated targets or workflows incompatible with hydrophobic bead surfaces.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Advancing Dual-Fluorescence

  2026-05-02

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables seamless, dual-fluorescence tracking of both mRNA delivery and translation with exceptional immune evasion. This APExBIO innovation bridges rapid optimization of nanoparticle carriers and robust protein expression readouts, streamlining next-generation gene delivery studies.

• Pharmacological and Clinical Profile of Palonosetron Hydroch

  2026-05-01

  This review summarizes a key reference study investigating the pharmacological selectivity, pharmacokinetics, and clinical performance of palonosetron hydrochloride as a 5-HT3 receptor antagonist for chemotherapy-induced and radiotherapy-induced nausea and vomiting (CINV/RINV). The study establishes its superior receptor selectivity and prolonged efficacy compared to prior agents, supporting its use in supportive cancer care.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-04-30

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and microscopy workflows where robust fluorescent signal and low background are required. It is not appropriate for applications involving non-rabbit primaries or direct detection without a compatible rabbit antibody.

• Ellagic Acid in Senescence-Targeted Assays: Beyond CK2 Inhib

  2026-04-30

  Explore the advanced role of Ellagic acid as a selective CK2 inhibitor in senescence-targeted assays. This article uniquely bridges machine learning-driven senolytic discovery with practical assay optimization for cancer biology research.

• Lactate Drives Macrophage HMGB1 Modification and Exosomal Re

  2026-04-29

  This study uncovers how lactate directly promotes HMGB1 lactylation and acetylation in macrophages, leading to its exosomal release and contributing to sepsis pathology. By elucidating the underlying signaling mechanisms, it identifies new intervention points for inflammatory signaling pathway research.

• Azathramycin A: Strategic Insights for Tuberculosis Research

  2026-04-29

  This thought-leadership article examines the mechanistic value and translational potential of Azathramycin A, a macrolide antibiotic, for Mycobacterium tuberculosis research. By integrating cutting-edge evidence, competitive analyses, and recommendations for experimental design, it provides actionable guidance for researchers seeking to address antibiotic resistance and optimize in vitro tuberculosis models.

• PD0325901: Advancing MEK Inhibition and TERT Regulation Insi

  2026-04-28

  Explore how PD0325901, a potent MEK inhibitor, enables advanced research into RAS/RAF/MEK/ERK pathway inhibition and TERT regulation. This article uniquely integrates recent APEX2/TERT findings and protocol guidance for oncology and stem cell assays.

• c-Myc tag Peptide: Mechanistic Insights for Next-Gen Immunoa

  2026-04-28

  Explore the scientific foundation and unique advantages of the c-Myc tag Peptide for precise immunoassays. This article delivers advanced mechanistic analysis and practical protocols, offering a deeper perspective on c-Myc Peptide applications in cell signaling and transcription factor studies.

• PD0325901: MEK Inhibitor Workflows for Precision Oncology

  2026-04-27

  PD0325901, a selective MEK inhibitor from APExBIO, empowers researchers to dissect and modulate the RAS/RAF/MEK/ERK pathway with unprecedented specificity. This guide delivers actionable protocol enhancements, troubleshooting insights, and evidence-based strategies for maximizing assay sensitivity and translational impact in cancer research.

• SB 431542: Precision ALK5 Inhibition for TGF-β Pathway Studi

  2026-04-27

  SB 431542 is a benchmark ALK5 inhibitor that enables reproducible disruption of TGF-β signaling in diverse biological contexts. Its selectivity and robust performance make it indispensable for probing cell proliferation, immunomodulation, and regenerative differentiation workflows.

16879 records 1/1126 page Next 12345 下5页 Last page